{"id":2955,"date":"2026-10-21T12:42:16","date_gmt":"2026-10-21T10:42:16","guid":{"rendered":"https:\/\/nanosmartlab.cnr.it\/?p=2955"},"modified":"2026-10-21T12:52:18","modified_gmt":"2026-10-21T10:52:18","slug":"from-benchtop-nanophotonics-to-bedside-diagnostics-dr-alessia-milano-presents-nanosmartlabs-sers-biosensor-breakthrough-at-bats-2026","status":"publish","type":"post","link":"https:\/\/nanosmartlab.cnr.it\/?p=2955","title":{"rendered":"From Benchtop Nanophotonics to Bedside Diagnostics: Dr. Alessia Milano Presents NanoSmartLab\u2019s SERS Biosensor Breakthrough at BATS 2026"},"content":{"rendered":"\n

Naples, Italy<\/strong> \u2014 At the IEEE International Workshop on Biomedical Applications, Technologies and Sensors (BATS) held in Naples, NanoSmartLab postdoctoral researcher Dr. Alessia Milano<\/strong> delivered an invited talk highlighting our group’s latest advancements in plasmonic biosensing. Presenting research that bridges nanophotonics, clinical diagnostics, and food safety, Dr. Milano showcased how Surface-Enhanced Raman Scattering (SERS) is paving the way for rapid, point-of-care (PoC) detection of Shiga toxins.<\/p>\n\n\n\n

The presented work, titled “Towards Point-of-Care and Food Safety Applications of SERS for Shiga Toxin Detection”<\/em><\/strong>, represents a multidisciplinary effort led by Dr. Lucia Petti alongside team members Alessia Milano, Amalia D’Avino, Valentina Marchesano, Domenico Sagnelli, Massimo Rippa, Bryan Guilcapi, and Lu Zhou. The research is carried out in close collaboration with Prof. Maurizio Brigotti (University of Bologna), Dr. Stefano Morabito (Istituto Superiore di Sanit\u00e0), and Dr. Gianluigi Ardissino (Center for HUS Control, Prevention and Management, Ospedale Maggiore Policlinico, Milan).<\/p>\n\n\n\n

\n
\"\"<\/figure>\n<\/figure>\n\n\n\n

The Diagnostic Challenge<\/h3>\n\n\n\n

Shiga toxin-producing Escherichia coli<\/em> (STEC) infections pose a grave threat to human health, frequently causing severe hemorrhagic diarrhea and progressing to Hemolytic Uremic Syndrome (HUS)\u2014a critical condition causing acute renal failure, predominantly in young children<\/sup>. Because Shiga toxins clear rapidly from blood serum within hours, early diagnosis is essential<\/sup>. However, conventional tools like ELISA, PCR, and Vero cell assays are hindered by long turnaround times, lack of subtyping capability, or inability to operate at the point of care<\/sup>.<\/p>\n\n\n\n

NanoSmartLab\u2019s Plasmonic Innovation<\/h3>\n\n\n\n

To overcome these diagnostic bottlenecks, NanoSmartLab developed a label-free SERS platform engineered for direct molecular fingerprinting of Shiga toxins<\/sup>:<\/p>\n\n\n\n

\n
\n

Scalable Nanofabrication<\/strong>: Transitioning from electron-beam lithography (EBL) metasurfaces to benchtop Marangoni self-assembly of gold nanoparticles (AuNPs), achieving an enhancement factor of 3x 10^7 at low production cost.<\/p>\n\n\n\n

Direct Serum Detection<\/strong>: Achieving a limit of detection (LOD) of 0.1 pM<\/strong> for Stx2 directly in human serum, eliminating the need for complex sample pre-processing or dilution<\/sup>.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure><\/div>
\"\"<\/figure><\/div>
\"\"<\/figure><\/div>
\"\"<\/figure><\/div>
\"\"<\/figure><\/div>
\"\"<\/figure><\/div><\/div>